Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:32 pm Unchanged | 13G | TOURMALINE BIO INC TRML | VIKING GLOBAL INVESTORS LP | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-14 4:31 pm Purchase | 13G | Ginkgo Bioworks Holdings Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 8.300% | 3,577,128 (New Position) | View |
| 2024-11-14 4:31 pm Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 1,481,146 1.600% | -4,678,000 (-75.95%) | View |
| 2024-11-14 4:31 pm Unchanged | 13G | PEPGEN INC PEPG | VIKING GLOBAL INVESTORS LP | 1,482,434 4.500% | 0 (Unchanged) | View |
| 2024-11-14 4:31 pm Sale | 13G | 4D Molecular Therapeutics Inc. FDMT | VIKING GLOBAL INVESTORS LP | 0 0.000% | -4,247,914 (Position Closed) | View |
| 2024-11-14 4:31 pm Sale | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 54,099,066 7.300% | -15,269,895 (-22.01%) | View |
| 2024-11-14 4:30 pm Sale | 13G | Viking Therapeutics Inc. VKTX | VIKING GLOBAL INVESTORS LP | 721,926 0.600% | -4,423,186 (-85.97%) | View |
| 2024-11-14 4:30 pm Sale | 13G | Verastem Inc. VSTM | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,531,829 (Position Closed) | View |
| 2024-11-06 5:04 pm Unchanged | 13D | BridgeBio Pharma Inc. BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 13.400% | 0 (Unchanged) | View |
| 2024-11-06 5:03 pm Unchanged | 13D | Cazoo Group Ltd CZOOF | VIKING GLOBAL INVESTORS LP | 2,142,728 43.800% | 0 (Unchanged) | View |
| 2024-09-30 4:29 pm Purchase | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VIKING GLOBAL INVESTORS LP | 9,753,293 5.100% | 9,753,293 (New Position) | View |
| 2024-08-20 8:42 pm Unchanged | 13D | BridgeBio Pharma Inc. BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 13.400% | 0 (Unchanged) | View |
| 2024-07-15 4:17 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | VIKING GLOBAL INVESTORS LP | 1,752,656 5.200% | 1,752,656 (New Position) | View |
| 2024-06-18 5:05 pm Sale | 13G | APi Group Corp APG | VIKING GLOBAL INVESTORS LP | 27,032,516 9.900% | -4,990,399 (-15.58%) | View |
| 2024-06-07 4:23 pm Purchase | 13G | INHIBRX BIOSCIENCES INC INBX | VIKING GLOBAL INVESTORS LP | 1,787,705 12.300% | 1,787,705 (New Position) | View |
| 2024-06-03 5:56 pm Sale | 13G | INHIBRX BIOSCIENCES INC INBX | VIKING GLOBAL INVESTORS LP | 0 0.000% | -7,150,826 (Position Closed) | View |
| 2024-03-20 6:05 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% | 29,544,805 (+101.51%) | View |
| 2024-03-01 4:18 pm Sale | 13G | APi Group Corp APG | VIKING GLOBAL INVESTORS LP | 32,022,915 12.300% | -10,494,242 (-24.68%) | View |
| 2024-02-28 4:28 pm Sale | 13G | RayzeBio Inc. RYZB | VIKING GLOBAL INVESTORS LP | 0 0.000% | -6,642,700 (Position Closed) | View |
| 2024-02-14 10:27 am Purchase | 13G | PHARVARIS N V REGISTERED PHVS | VIKING GLOBAL INVESTORS LP | 3,656,923 7.000% | 425,000 (+13.15%) | View |